Investor Alert

New York Markets Open in:

Market Pulse Archives

June 14, 2021, 5:26 p.m. EDT

Biotech Century Therapeutics to offer 10.6 million shares in IPO, priced at $18 to $20 each

Watchlist Relevance

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Century Therapeutics Inc. (IPSC)

or Cancel Already have a watchlist? Log In

By Ciara Linnane


Biotech Century Therapeutics Inc. /zigman2/quotes/210490648/composite IPSC +1.76% set terms for its initial public offering on Monday, with plans to offer 10.6 million shares priced at $18 to $20 each. The company has applied to list on Nasdaq, under the ticker symbol "IPSC." JP Morgan, BofA Securities, SVB Leerink and Piper Sandler are underwriting the deal. Proceeds will be used to fund pre-clinical activity and research and development, as well as working capital and general corporate purposes. "We are an innovative biotechnology company developing transformative allogeneic cell therapies to create products for the treatment of both solid tumor and hematological malignancies with significant unmet medical need," the company says in its prospectus.

US : U.S.: Nasdaq
$ 4.63
+0.08 +1.76%
Volume: 99,934
Jan. 27, 2023 4:00p
P/E Ratio
Dividend Yield
Market Cap
$273.05 million
Rev. per Employee

Get news alerts on Century Therapeutics Inc. — or create your own.
This Story has 0 Comments
Be the first to comment
More News In

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.